To further determine if blocking HER2 signaling had the potential to mediate IPF lung fibroblast invasion, we treated IPF lung fibroblasts with Lapatinib in migration and invasion assays. This evidence concerns the gene ERBB2 and idiopathic interstitial pneumonia.